Editorial Comment to Survival beyond cabazitaxel for metastatic castration-resistant prostate cancer

Yamamoto, Yoshiyuki; Nonomura, Norio

International Journal of Urology, 2024, 31(7), 831-832

Number of Access:215（2025-06-27 13:46 Counts）

Identifier to cite or link to this item: https://hdl.handle.net/11094/97093

Link to primary information 

File Format Terms of use Size Views Date.Available Description information
IntJUrol_iju_15458 pdf None 91.3 KB 121 2024.07.04  
Creative Commons : Attribution

Item Information

Output File Export EndNote Basic Export Mendeley

Title
Editorial Comment to Survival beyond cabazitaxel for metastatic castration-resistant prostate cancer
Creator
NRID
1000090759557 1000090759557
researchmap permalink
yoshi229 yoshi229
CreatorName
Yamamoto, Yoshiyuki
NRID
1000030263263 1000030263263
researchmap permalink
read0185096 read0185096
Scopus Author ID
7005880662 7005880662
CreatorName
Nonomura, Norio
Description
Yamamoto Y., Nonomura N.. Editorial Comment to Survival beyond cabazitaxel for metastatic castration-resistant prostate cancer. International Journal of Urology, (2024); https://doi.org/10.1111/iju.15458.
This article refers to: Blas L., Shiota M., Tanegashima T., et al. Survival beyond cabazitaxel for metastatic castration-resistant prostate cancer. International Journal of Urology, (2024); https://doi.org/10.1111/iju.15449.
Publisher
John Wiley and Sons Inc
Source Title
International Journal of Urology
Volume (Issue)
31(7)
Page
831-832
Date of Issued
2024-04-04
Language
English
Handle URL
https://hdl.handle.net/11094/97093
PISSN
09198172
eISSN
14422042
Relation.isIdenticalTo
DOI (Publisher Version)
https://doi.org/10.1111/iju.15458
Access Rights
open access
CopyRight
This article is licensed under a Creative Commons Attribution 4.0 International License.
oaire:version
Version of Record
Category
学術雑誌論文 Journal Article